Literature DB >> 19447733

Allergic and irritant contact dermatitis.

Audrey Nosbaum1, Marc Vocanson, Aurore Rozieres, Anca Hennino, Jean-François Nicolas.   

Abstract

Irritant and allergic contact dermatitis are common inflammatory skin diseases induced by repeated skin contact with low molecular weight chemicals, called xenobiotics or haptens. Although both diseases may have similar clinical presentations, they can be differentiated on pathophysiological grounds. Irritant contact dermatitis (ICD) is a non-specific inflammatory dermatitis brought about by activation of the innate immune system by the pro-inflammatory properties of chemicals. Allergic contact dermatitis (ACD) corresponds to a delayed-type hypersensitivity response with a skin inflammation mediated by hapten-specific T cells. Recent progress in the pathophysiology of chemical-induced skin inflammation has shown that ICD and ACD are closely associated and that the best way to prevent ACD is to develop strategies to avoid ICD. The immunological diagnosis of ICD or ACD requires investigation of the presence (ACD) or absence (ICD) of antigen-specific T cells. The detection of T cells can be performed in the skin (collected from ACD lesions or positive patch tests) and/or in the blood, particularly by using the enzyme-linked immunospot assay (ELISPOT). This method, recently developed in ACD to metals, offers a new biological tool enabling the immunobiological diagnosis of ACD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19447733     DOI: 10.1684/ejd.2009.0686

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  34 in total

1.  Assessment of the in vitro dermal irritation potential of cerium, silver, and titanium nanoparticles in a human skin equivalent model.

Authors:  Vivek A Miyani; Michael F Hughes
Journal:  Cutan Ocul Toxicol       Date:  2016-08-08       Impact factor: 1.820

Review 2.  The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis.

Authors:  Joshua L Owen; Paras P Vakharia; Jonathan I Silverberg
Journal:  Am J Clin Dermatol       Date:  2018-06       Impact factor: 7.403

3.  A critical role for thymic stromal lymphopoietin in nickel-induced allergy in mice.

Authors:  Meinar Nur Ashrin; Rieko Arakaki; Akiko Yamada; Tomoyuki Kondo; Mie Kurosawa; Yasusei Kudo; Megumi Watanabe; Tetsuo Ichikawa; Yoshio Hayashi; Naozumi Ishimaru
Journal:  J Immunol       Date:  2014-03-26       Impact factor: 5.422

Review 4.  Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis.

Authors:  Julia K Gittler; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2012-08-28       Impact factor: 10.793

5.  Histone deacetylases inhibitor Trichostatin A ameliorates DNFB-induced allergic contact dermatitis and reduces epidermal Langerhans cells in mice.

Authors:  Yu-Ling Shi; Jun Gu; Jang-June Park; Jun-Yang Park; Ying-Ping Xu; Fu-Shin Yu; Li Zhou; Qing-Sheng Mi
Journal:  J Dermatol Sci       Date:  2012-09-07       Impact factor: 4.563

6.  Role of ROS and HMGB1 in contact allergen-induced IL-18 production in human keratinocytes.

Authors:  Valentina Galbiati; Angela Papale; Corrado L Galli; Marina Marinovich; Emanuela Corsini
Journal:  J Invest Dermatol       Date:  2014-04-29       Impact factor: 8.551

7.  An essential role for TAK1 in the contact hypersensitivity response.

Authors:  Yan G Zhao; Yunqi Wang; Weidong Hao; Yisong Y Wan
Journal:  Cell Mol Immunol       Date:  2011-05-09       Impact factor: 11.530

8.  Integrin αE(CD103) Is Involved in Regulatory T-Cell Function in Allergic Contact Hypersensitivity.

Authors:  Andrea Braun; Nadin Dewert; Fiona Brunnert; Viktor Schnabel; Jan-Hendrik Hardenberg; Beatrice Richter; Karolin Zachmann; Sascha Cording; Anna Claßen; Richard Brans; Alf Hamann; Jochen Huehn; Michael P Schön
Journal:  J Invest Dermatol       Date:  2015-07-23       Impact factor: 8.551

Review 9.  Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases.

Authors:  Zheng Zhang; Pei-Chin Tsai; Tannaz Ramezanli; Bozena B Michniak-Kohn
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-02-05

Review 10.  The Unique Molecular Signatures of Contact Dermatitis and Implications for Treatment.

Authors:  Alexandra Leonard; Emma Guttman-Yassky
Journal:  Clin Rev Allergy Immunol       Date:  2019-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.